152 related articles for article (PubMed ID: 7295882)
1. Isosorbide 5-mononitrate pharmacokinetics in humans.
Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
[TBL] [Abstract][Full Text] [Related]
2. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.
Taylor T; Chasseaud LF; Doyle E; Darragh A; O'Kelly DA; Fitzgerald D
Biopharm Drug Dispos; 1980; 1(3):149-56. PubMed ID: 7448342
[TBL] [Abstract][Full Text] [Related]
4. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
5. Newer aspects of the pharmacokinetics of organic nitrates.
Chasseaud LF
Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
[TBL] [Abstract][Full Text] [Related]
6. Isosorbide 5-mononitrate kinetics.
Major RM; Taylor T; Chasseaud LF; Darragh A; Lambe RF
Clin Pharmacol Ther; 1984 May; 35(5):653-9. PubMed ID: 6713775
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of organic nitrates.
Bogaert MG
Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of isosorbide mononitrate.
Abshagen UW
Am J Cardiol; 1992 Nov; 70(17):61G-66G. PubMed ID: 1449102
[TBL] [Abstract][Full Text] [Related]
11. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
Bogaert MG; Rosseel MT; Boelaert J; Daneels R
Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
[TBL] [Abstract][Full Text] [Related]
12. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man.
Bruyneel K; Rosseel MT; Bogaert MG
Arzneimittelforschung; 1982; 32(7):769-73. PubMed ID: 6889879
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion.
Bergami A; Bernasconi R; Caccia S; Leopaldi D; Mizrahi J; Sardina M; Urso R; Warrington SJ; Latini R
J Clin Pharmacol; 1997 Sep; 37(9):828-33. PubMed ID: 9549637
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-state.
Taylor T; Chasseaud LF; Major RM; Leaf FC; Bonn R; Darragh A; Lambe RF
Biopharm Drug Dispos; 1985; 6(2):119-29. PubMed ID: 4005392
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.
Chasseaud LF; Down WH; Grundy RK
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):157-60. PubMed ID: 1233213
[TBL] [Abstract][Full Text] [Related]
18. Absorption and excretion of isosorbide dinitrate and isosorbide-2-mononitrate in dogs.
Cayen MN; Hicks D; Karounis J; Dvornik D
J Pharm Pharmacol; 1983 May; 35(5):312-6. PubMed ID: 6134800
[TBL] [Abstract][Full Text] [Related]
19. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.
Vree TB; Dammers E; Valducci R
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327
[TBL] [Abstract][Full Text] [Related]
20. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
